Infosys Ltd (INFY) reports robust free cash flow and operating margins despite a sequential revenue decline and cautious FY26 ...

At a market cap of 4.7B EUR and EV/EBITDA of 4.8, Arkema is attractively priced, even with a potential 15% EBITDA reduction.

Tard's growth, undervaluation, and strong performance make it a top investment pick. Click to read more about why I've rated ATD:CA as a Buy.

There are five major reasons to believe Altria shares can be a safe harbor in nearly any storm. As a nicotine company, Altria ...

If it has been hard for you to sleep at night, you might want to take a look at this exchange-traded fund (ETF) that tracks ...

Despite the noise, it's hard to tune out this industry leader, which still boasts an audience of 160 million listeners across ...

Australian buy-now, pay-later firm Zip Co posted record quarterly cash earnings on Wednesday, helped by strong performance ...

The interim dividend of ₹6, declared by the Board in January will be considered as the final dividend for FY25 ...

Moulineaux, France - April 17, 2025 Pluxee continues to deliver solid business and financial performance in H1 and raises its Fiscal 2025 Recurring EBITDA ...

The software sector has been booming in recent years, as businesses move more and more of their office work into the digital ...

Looking to buffer your portfolio against Trump’s tariffs? Here are four stocks that should keep you safe. The post 4 ...